Trial Profile
A Personalized Randomized Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary) ; Interferon gamma-1b (Primary)
- Indications Macrophage activation syndrome; Sepsis
- Focus Therapeutic Use
- Acronyms PROVIDE
- 28 Jul 2020 Status changed from active, no longer recruiting to completed.
- 17 Feb 2020 Status changed from recruiting to active, no longer recruiting.
- 06 Jan 2018 Status changed from not yet recruiting to recruiting.